New hope for kids with hard-to-treat cancers: targeted radiation plus pill
Disease control
Recruiting now
This study is for children and teens (ages 3-18) whose solid tumors have come back or not responded to standard treatments. It combines a radioactive drug (Lutathera) that targets tumor cells with a pill (olaparib) that may make the radiation more effective. The goal is to see if…
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated Apr 23, 2026 12:45 UTC